Beijing, China

Xu Yan

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2015-2023

Loading Chart...
Loading Chart...
7 patents (USPTO):

Title: Xu Yan - Innovator in Pyrrolo-Aromatic Compounds and Display Technology

Introduction

Xu Yan is a prominent inventor based in Beijing, China, known for his contributions to the fields of medicinal chemistry and display technology. With a total of 7 patents to his name, he has made significant strides in developing innovative solutions that address complex challenges in these areas.

Latest Patents

One of Xu Yan's latest patents is focused on pyrrolo-aromatic heterocyclic compounds, which includes a preparation method and medical applications. This invention specifically relates to a compound that acts as a BTK kinase inhibitor, which can be utilized in treating diseases associated with BTK kinase activity, such as inflammations, autoimmune disorders, and cancers. Another notable patent involves a method for repairing display panels. This method includes determining the location of bright spot defects and setting a repair region to effectively address these issues, enhancing the overall functionality of display technology.

Career Highlights

Throughout his career, Xu Yan has worked with notable companies, including IBM and BOE Technology Group Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking innovations in technology and medicine.

Collaborations

Xu Yan has collaborated with esteemed professionals in his field, including Robert G. Biskeborn and Calvin S. Lo. These partnerships have fostered an environment of creativity and innovation, leading to the development of impactful inventions.

Conclusion

Xu Yan's work exemplifies the spirit of innovation in both medicinal chemistry and display technology. His contributions continue to influence these fields, showcasing the importance of research and development in addressing real-world challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…